Cross Shore Discovery Fund: insider trades · United States · SEC (Form 4)

About Cross Shore Discovery Fund

Cross Shore Discovery Fund is a U.S.-based investment vehicle registered with the SEC and historically connected to the U.S. listed-fund universe. It is structured as a Delaware statutory trust and was based in Cincinnati, Ohio, at 225 Pictoria Drive, Suite 450, while the investment adviser, Cross Shore Capital Management, LLC, operated from Great Neck, New York. The fund was created in 2012, and public registry data now shows it as inactive following a liquidation effective December 31, 2024. For investors reviewing SEC Form 4-related insider activity, that status change is a crucial context point. ([lei.bloomberg.com](https://lei.bloomberg.com/leis/view/549300FIOYAHZ5RDKV81)) In business terms, Cross Shore Discovery Fund is not an operating company with products, factories, or consumer brands. Its value proposition is investment management: the fund’s adviser aimed to deliver superior risk-adjusted returns across a full market cycle, with lower drawdowns and volatility than broad U.S. equity indices. The fund’s historical portfolio construction leaned toward growth-oriented strategies, with significant exposure to information technology and biotechnology. That made the vehicle more of a specialized growth allocation tool than a broad market fund. ([sec.gov](https://www.sec.gov/Archives/edgar/data/0001609706/000158064223003164/cross-shore_ncsr.htm)) From a competitive standpoint, the fund competed in the niche segment of alternative and specialized investment products, where performance depends on asset allocation discipline, manager selection, and sector positioning. Its annual report notes that technology exposure had previously been a source of underperformance, prompting a reduction in that weighting, while biotechnology remained an important sleeve in the portfolio. That suggests a manager willing to rebalance exposure tactically rather than remain rigidly committed to a single theme. ([sec.gov](https://www.sec.gov/Archives/edgar/data/0001609706/000158064223003164/cross-shore_ncsr.htm)) Geographically, the fund was firmly anchored in the United States, with the principal executive office in Cincinnati, Ohio, and the adviser in New York. For French, Belgian, and Swiss investors, the relevant lens is therefore U.S. regulatory oversight, SEC reporting, and the fund’s status as a U.S. investment company. The recent tender-offer filing and the registered liquidation event indicate that the fund’s lifecycle has moved into wind-down mode, which is materially more important than any standard operating KPI. ([streetinsider.com](https://www.streetinsider.com/SEC%2BFilings/Form%2BSC%2BTO-I%2BCROSS%2BSHORE%2BDISCOVERY%2BFiled%2Bby%3A%2BCROSS%2BSHORE%2BDISCOVERY%2BFUND/23551667.html)) In practical terms, Cross Shore Discovery Fund should be understood as a small, specialized U.S. fund vehicle that historically targeted growth, technology, and biotechnology opportunities, but whose recent regulatory record shows liquidation rather than expansion. For equity analysts and investors, the most relevant takeaways are the U.S. domicile, the SEC-regulated structure, the growth-biased investment mandate, and the fact that the fund no longer appears to be an ongoing active operating platform. ([sec.gov](https://www.sec.gov/Archives/edgar/data/0001609706/000158064223003164/cross-shore_ncsr.htm))